According to the Financial Intelligence APP, Abbott Laboratories (ABT.US) opened strong on Friday, marking the largest intraday gain since April 2023, up over 5% to $119.61 at the time of writing. On the news front, Abbott reported third-quarter sales of $10.64 billion, an approximately 5% year-on-year increase, with analysts expecting $10.55 billion; adjusted earnings per share of $1.21, an approximately 6% year-on-year increase. The company expects to maintain its full-year organic sales growth guidance in the range of 9.5-10%; adjusted earnings per share are expected to be between $4.64 and $4.70, previously expected to be $4.61 to $4.71. In addition, the company announced a new share buyback plan of up to $7 billion.